Skip to content

Analgesic Efficacy of Ultrasound-Guided Liposomal Bupivacaine in Transversalis Fascia Plane Block for Post-Cesarean Section Pain Management: A Prospective Study

Analgesic Efficacy of Ultrasound-Guided Liposomal Bupivacaine in Transversalis Fascia Plane Block for Post-Cesarean Section Pain Management: A Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111261
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Sponsors

Neijiang Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Essential Criteria: Age >= 18 years; Singleton term pregnancy ( >= 37 weeks gestation) ; ASA Physical Status Class I–II with stable health condition. Surgical Conditions: Planned scheduled cesarean delivery under spinal or combined spinal-epidural anesthesia; Absence of contraindications to neuraxial anesthesia (e.g., coagulation disorders, infection at puncture site) ; Voluntary Participation: Signed written informed consent form .

Exclusion criteria

Exclusion criteria: Health-Related Exclusions: Severe hepatic/renal insufficiency or metabolic disorders; Documented allergy to ropivacaine or other local anesthetics; Chronic pain syndromes or long-term opioid use (>3 months). Surgery-Related Exclusions: History of >=3 cesarean deliveries or complex obstetric conditions (e.g., placenta accreta spectrum, placenta previa); Requirement for concurrent procedures (e.g., hysterectomy) that may confound pain assessment. Compliance Exclusions: Severe psychiatric disorders, communication barriers (e.g., aphasia), or inability to complete follow-up; Refusal to use patient-controlled intravenous analgesia (PCIA) or multimodal analgesia regimen. Key Terminology Validation: Placenta accreta spectrum: Internationally standardized term for abnormal placental invasion [FIGO 2018] PCIA (Patient-Controlled Intravenous Analgesia): Preferred over "postoperative infusion pump" in academic contexts [ASA Guidelines 2023] Chronic pain syndromes: Includes fibromyalgia, neuropathic pain, etc. [IASP Classification] Long-term opioid use: Defined as daily opioids for >3 months [CDC Guideline 2022

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS);

Secondary

MeasureTime frame
Postoperative analgesic drug dosage;Postoperative adverse reaction incidence: nausea, vomiting, skin itching, allergic reactions;first ambulation time;

Countries

China

Contacts

Public ContactLi Qiyang

Neijiang Maternal and Child Health Hospital

634558927@qq.com+86 182 2803 0419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026